Gracecast Lung Cancer Audio
ASCO 2012 LC Highlights: Dr. Joel Neal on the MEK Inhibitor Selumetinib in KRAS Mutation-Positive NSCLC (audio)
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:05:10
- Mas informaciones
Informações:
Sinopsis
Dr. Joel Neal reviews the favorable results with chemo combined with the novel targeted therapy selumetinib, a MEK inhibitor, in KRAS mutatino-positive patients with advanced non-small cell lung cancer (NSCLC).
